A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Piramal Enterprises Limited

ClinicalTrials.gov Identifier:

NCT00824343

First received: January 15, 2009

Last updated: January 23, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)